Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis.
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.
Genetic and epigenetic fine mapping of causal autoimmune disease variants.
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.
Ozone: a multifaceted molecule with unexpected therapeutic activity.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Historical Issues of Optic neuritis and Sensory Disorder in Persian Traditional Medicine.
Proceedings of the European Charcot Foundation Symposium A Reappraisal of Nutrition and Environment in Multiple Sclerosis, European Charcot Foundation Symposium, December 2-4, 2010, Fiuggi, Italy.
Speedy eye movements in multiple sclerosis: Association with performance on visual and nonvisual cognitive tests.
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
Warner Chilcott sells Vectrin product line to Medicis
HLA-B7-Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis.
Drug-induced thrombocytopenia secondary to natalizumab treatment.
The risk of smoking on multiple sclerosis: a meta-analysis based on 20,626 cases from case-control and cohort studies.
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
Imaging of the spine at 3 tesla.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.

Pages